Navigation Links
Winner of Pierre Delmas Prize announced at World Congress on Osteoporosis 2010
Date:5/5/2010

The prestigious Pierre Delmas Prize: An ESCEO-IOF/Servier Achievement Award was awarded today to Professor Pierre Jean Meunier, Professor Emeritus at the Claude Bernard University of Lyon, France.

This important new annual scientific award is named in honour of the late Pierre D. Delmas, the world renowned researcher and co-founder of the International Osteoporosis Foundation (IOF). The grant of 40,000 Euros, courtesy of Servier, is awarded to Professor Meunier in honour of his outstanding and major scientific contributions to the study of bone and mineral diseases.

In presenting the award, ESCEO President Professor Jean-Yves Reginster lauded Professor Meunier for his influential work in the field of osteoporosis and rheumatic diseases as well as his eminent role as a mentor and editor in the bone arena. "Indeed it is especially fitting that this award goes to Professor Meunier, as he was an early and influential mentor to the young Pierre Delmas," stated Professor Reginster.

Servier CEO Dr. Jean-Philippe Seta congratulated the winner and noted, "In sponsoring this Prize, Servier underlines its commitment to furthering advances in rheumatology and osteoporosis treatment."

Professor Meunier has published more than 370 scientific manuscripts and books, and is recipient of several important awards including the IBMS John Haddad Prize and the ASBMR Frederic C. Bartter Award. He was named Officer of the Ordre des Palmes Acadmiques, awarded by the French government for services in education. Among many notable positions, Professor Meunier was the President of the European Foundation for Osteoporosis (from 1990-1996), Founder and Director of an INSERM Research Unit on the pathology of calcified tissue, Founding Board Member of the International Osteoporosis Foundation and Founder and Honorary President of the Groupe de Recherche et d'Informations sur les Ostoporoses (GRIO).

The award was presented at the opening ceremony of th
'/>"/>

Contact: L. Misteli
lmisteli@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Winner Medical Group inc. Prices Offering of 1,380,000 Shares of Common Stock
2. Dr. Alecia Willis honored as the 2010 Signature Genomic Laboratories Travel Award winner
3. Joshua E. Neimark Memorial Travel Assistance Award winners
4. Biophysical Society announces winners of 2010 Student Travel Awards
5. Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners
6. Leibniz Prize 2010: 10 winners receive honor, prize money and idyllic freedom
7. 2009 winner of the Manpei Suzuki international prize for diabetes research announced
8. Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix
9. Winners of the 2009 AAAS Kavli science journalism awards
10. CSIRO medal winners
11. Entomological Society of America names 2009 award winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... 26, 2015 ATL Technology, LLC, a top provider ... in single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Jose, Costa Rica ). This acquisition will ... with ATL Technology,s existing facility in Costa ...
(Date:6/24/2015)... 24, 2015 This report provides market analysis ... six years. It contains an analysis of the drivers, ... their impact from the short, medium, and long term ... industry, market, and technology trends that currently, prevail in ... concerned authorities to efficiently manage the increasing marine traffic ...
(Date:6/23/2015)... 22, 2015 Research ... of the "Body-Worn Temperature Sensors Market - ... Forecast 2014 - 2020" report to their ... of the global body-worn temperature sensors market. The ... on the basis of types, care setting, patient ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... oysters on a hot sunny afternoon? Make the most ... shown that global warming increases the sensitivity of oysters ... in polluted areas. Dr. Gisela Lannig from the University ... cadmium poisoning in eastern oysters (Crassostrea virginica) on Monday ...
... a highly effective analgesic, its clinical utility is severely ... for increasing doses to maintain analgesic effect, and the ... of Current Biology, researchers report a new study showing ... along with small doses of two versions of methadone, ...
... for viral-based therapies for cancer , Researchers at Columbia ... work to develop the next generation of effective viral-based ... with genetically engineered viruses studied in mice, published today ... the National Academy of Sciences (PNAS), bring us significantly ...
Cached Biology News:Opiate cocktail may spare cells from morphine's dark side 2Columbia scientists develop cancer terminator viruses 2Columbia scientists develop cancer terminator viruses 3
(Date:6/30/2015)... Tampa, Florida (PRWEB) , ... June 30, 2015 ... ... medical cannabis digital media company, launched “Cannavoices,” an unprecedented digital video and ... the largest but also the most dynamic collection of legal medical cannabis stories ...
(Date:6/29/2015)...   Pharnext SAS today announced that data related ... of Charcot-Marie-Tooth Type 1A (CMT1A), is being presented in four ... Society (PNS) Biennial Meeting at the Quebec Congress Center in ... July 2, 2015. At Poster Viewing Session 4, ... to 7p.m. EDT: Poster 23: "A Meta-Analysis ...
(Date:6/29/2015)... ... June 29, 2015 , ... The global microfluidics ... the forecast period (2015 to 2020). The market is mainly driven by the ... funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging ...
(Date:6/29/2015)... June 29, 2015  AACC, a global scientific ... through laboratory medicine, is pleased to announce that ... Chemistry , has increased to 7.9 in the ... places Clinical Chemistry in the top ... significant influence of the research it publishes on ...
Breaking Biology Technology:Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3
... took his computer to boot up, Klui began to think ... enormous quantities of data, but they are slow; every time ... is transferred from the hard disk into RAM (random access ... energy consumption runs into the hundreds of millions of dollars ...
... Nov. 15, 2010, PRNewswire-Asia/ -- Tiens Biotech Group (USA), Inc. (the ... www.tiens-bio.com , today announced financial results ... Revenue for the third quarter of 2010 was $10.4 ... Revenue for the nine months ended September 30, 2010 was $30.0 ...
... Celladon Corp., a biopharmaceutical company focused on ... cardiovascular diseases, today announced that 12-month data from ... demonstrated significant improvements in clinical outcomes and key ... with the genetically-targeted enzyme replacement therapy. ...
Cached Biology Technology:Racetrack memory 2Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 2Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 3Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 4Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 5Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 6Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 7Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 8Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 9Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo 2Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo 3Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo 4